文献速递脑血管病外科

采用伽玛刀放射外科疗效评分标准评估Spetzler-Ponce A级和B级动静脉畸形显微外科治疗的前瞻性队列研究

Microsurgery for Spetzler-Ponce Class A and B arteriovenous malformations utilizing an outcome score adopted from Gamma Knife radiosurgery: a prospective cohort study.
PubMed 文献 · J Neurosurg · 2016-12-23

该前瞻性队列研究将伽玛刀放射外科的有利结局定义应用于脑动静脉畸形显微外科,纳入562例Spetzler-Ponce A级或B级患者,分析有利结局的预测因素并建立预测模型,结果显示最大直径、 eloquent位置和深静脉引流是显著预测因素。

要点

  • 有利结局定义为末次随访无复发或残留、无手术或栓塞并发症、改良Rankin量表评分>1分。
  • 最大直径连续变量OR 0.62(95%CI 0.51-0.76)、非 eloquent位置OR 0.23(95%CI 0.12-0.43)、无深静脉引流OR 0.19(95%CI 0.10-0.36)为有利结局的显著预测因素。
  • 模型预测A级bAVM显微外科后8年有利结局范围为88%-99%,B级为62%-90%。

核心结论

  • 源自伽玛刀放射外科的有利结局可用于显微外科队列系列以辅助治疗推荐。
  • 对于最大直径小于2.5 cm且无深静脉引流或 eloquent位置的bAVM患者,以及所有直径的Spetzler-Ponce A级bAVM患者,显微外科后8年至少90%的病例可获得有利结局。
  • 对于B级bAVM患者,仅最大直径刚超过6 cm或更小且无深静脉引流或 eloquent位置的病变可接近该有利结局率。

研究设计与样本

  • 前瞻性显微外科队列分析,纳入675例接受治疗或因感知手术风险被拒绝手术的患者中的562例Spetzler-Ponce A级或B级bAVM患者。
  • 排除Spetzler-Ponce C级bAVM患者以避免极端选择偏倚。

主要发现

  • 逻辑回归显示最大直径连续变量OR 0.62(95%CI 0.51-0.76)、非 eloquent位置OR 0.23(95%CI 0.12-0.43)、无深静脉引流OR 0.19(95%CI 0.10-0.36)为有利结局的显著预测因素。
  • 模型预测A级bAVM显微外科后8年有利结局范围为88%-99%。
  • 模型预测B级bAVM显微外科后8年有利结局范围为62%-90%。

关键数值与推荐

  • 有利结局定义为末次随访无bAVM复发或残留、无手术或术前栓塞并发症、治疗后12个月改良Rankin量表评分>1分。
  • 因感知风险被拒绝手术但原本适合手术的患者被纳入为无有利结局。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE The purpose of this study was to adapt and apply the extended definition of favorable outcome established for Gamma Knife radiosurgery (GKRS) to surgery for brain arteriovenous malformations (bAVMs). The aim was to derive both an error around the point estimate and a model incorporating angioarchitectural features in order to facilitate comparison among different treatments. METHODS A prospective microsurgical cohort was analyzed. This cohort included patients undergoing embolization who did not proceed to microsurgery and patients denied surgery because of perceived risk of treatment. Data on bAVM residual and recurrence during long-term follow-up as well as complications of surgery and preoperative embolization were analyzed. Patients with Spetzler-Ponce Class C bAVMs were excluded because of extreme selection bias. First, patients with a favorable outcome were identified for both Class A and Class B lesions. Patients were considered to have a favorable outcome if they were free of bAVM recurrence or residual at last follow-up, with no complication of surgery or preoperative embolization, and a modified Rankin Scale score of more than 1 at 12 months after treatment. Patients who were denied surgery because of perceived risk, but would otherwise have been candidates for surgery, were included as not having a favorable outcome. Second, the authors analyzed favorable outcome from microsurgery by means of regression analysis, using as predictors characteristics previously identified to be associated with complications. Third, they created a prediction model of favorable outcome for microsurgery dependent upon angioarchitectural variables derived from the regression analysis. RESULTS From a cohort of 675 patients who were either treated or denied surgery because of perceived risk of surgery, 562 had Spetzler-Ponce Class A or B bAVMs and were included in the analysis. Logistic regression for favorable outcome found decreasing maximum diameter (continuous, OR 0.62, 95% CI 0.51-0.76), the absence of eloquent location (OR 0.23, 95% CI 0.12-0.43), and the absence of deep venous drainage (OR 0.19, 95% CI 0.10-0.36) to be significant predictors of favorable outcome. These variables are in agreement with previous analyses of microsurgery leading to complications, and the findings support the use of favorable outcome for microsurgery. The model developed for angioarchitectural features predicts a range of favorable outcome at 8 years following microsurgery for Class A bAVMs to be 88%-99%. The same model for Class B bAVMs predicts a range of favorable outcome of 62%-90%. CONCLUSIONS Favorable outcome, derived from GKRS, can be successfully used for microsurgical cohort series to assist in treatment recommendations. A favorable outcome can be achieved by microsurgery in at least 90% of cases at 8 years following microsurgery for patients with bAVMs smaller than 2.5 cm in maximum diameter and, in the absence of either deep venous drainage or eloquent location, patients with Spetzler-Ponce Class A bAVMs of all diameters. For patients with Class B bAVMs, this rate of favorable outcome can only be approached for lesions with a maximum diameter just above 6 cm or smaller and without deep venous drainage or eloquent location.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Morgan MK, Hermann Wiedmann MK, Stoodley MA, et al. Microsurgery for Spetzler-Ponce Class A and B arteriovenous malformations utilizing an outcome score adopted from Gamma Knife radiosurgery: a prospective cohort study. J Neurosurg. 2016. PMID: 28009228. doi:10.3171/2016.8.JNS161275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。